Your browser doesn't support javascript.
loading
Characterizing COVID-19 and Influenza Illnesses in the Real World via Person-Generated Health Data.
Shapiro, Allison; Marinsek, Nicole; Clay, Ieuan; Bradshaw, Benjamin; Ramirez, Ernesto; Min, Jae; Trister, Andrew; Wang, Yuedong; Althoff, Tim; Foschini, Luca.
Afiliación
  • Shapiro A; Evidation Health, Inc., San Mateo, CA 94401, USA.
  • Marinsek N; Evidation Health, Inc., San Mateo, CA 94401, USA.
  • Clay I; Evidation Health, Inc., San Mateo, CA 94401, USA.
  • Bradshaw B; Evidation Health, Inc., San Mateo, CA 94401, USA.
  • Ramirez E; Evidation Health, Inc., San Mateo, CA 94401, USA.
  • Min J; Evidation Health, Inc., San Mateo, CA 94401, USA.
  • Trister A; Bill and Melinda Gates Foundation, Seattle, WA 98109, USA.
  • Wang Y; Department of Statistics and Applied Probability, University of California Santa Barbara, Santa Barbara, CA 93106, USA.
  • Althoff T; Allen School of Computer Science & Engineering, University of Washington, Seattle, WA 98115, USA.
  • Foschini L; Evidation Health, Inc., San Mateo, CA 94401, USA.
Patterns (N Y) ; 2(1): 100188, 2021 Jan 08.
Article en En | MEDLINE | ID: mdl-33506230
The fight against COVID-19 is hindered by similarly presenting viral infections that may confound detection and monitoring. We examined person-generated health data (PGHD), consisting of survey and commercial wearable data from individuals' everyday lives, for 230 people who reported a COVID-19 diagnosis between March 30, 2020, and April 27, 2020 (n = 41 with wearable data). Compared with self-reported diagnosed flu cases from the same time frame (n = 426, 85 with wearable data) or pre-pandemic (n = 6,270, 1,265 with wearable data), COVID-19 patients reported a distinct symptom constellation that lasted longer (median of 12 versus 9 and 7 days, respectively) and peaked later after illness onset. Wearable data showed significant changes in daily steps and prevalence of anomalous resting heart rate measurements, of similar magnitudes for both the flu and COVID-19 cohorts. Our findings highlight the need to include flu comparator arms when evaluating PGHD applications aimed to be highly specific for COVID-19.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Patterns (N Y) Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Patterns (N Y) Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos